Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global Sustained Release Injectables Market Size Analysis from 2022 to 2027

1.5.1 Global Sustained Release Injectables Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global Sustained Release Injectables Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global Sustained Release Injectables Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: Sustained Release Injectables Industry Impact

Chapter 2 Global Sustained Release Injectables Competition by Types, Applications, and Top Regions and Countries

2.1 Global Sustained Release Injectables (Volume and Value) by Type

2.1.1 Global Sustained Release Injectables Consumption and Market Share by Type (2016-2021)

2.1.2 Global Sustained Release Injectables Revenue and Market Share by Type (2016-2021)

2.2 Global Sustained Release Injectables (Volume and Value) by Application

2.2.1 Global Sustained Release Injectables Consumption and Market Share by Application (2016-2021)

2.2.2 Global Sustained Release Injectables Revenue and Market Share by Application (2016-2021)

2.3 Global Sustained Release Injectables (Volume and Value) by Regions

2.3.1 Global Sustained Release Injectables Consumption and Market Share by Regions (2016-2021)

2.3.2 Global Sustained Release Injectables Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Sustained Release Injectables Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global Sustained Release Injectables Consumption by Regions (2016-2021)

4.2 North America Sustained Release Injectables Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia Sustained Release Injectables Sales, Consumption, Export, Import (2016-2021)

4.4 Europe Sustained Release Injectables Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia Sustained Release Injectables Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia Sustained Release Injectables Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East Sustained Release Injectables Sales, Consumption, Export, Import (2016-2021)

4.8 Africa Sustained Release Injectables Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania Sustained Release Injectables Sales, Consumption, Export, Import (2016-2021)

4.10 South America Sustained Release Injectables Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America Sustained Release Injectables Market Analysis

5.1 North America Sustained Release Injectables Consumption and Value Analysis

5.1.1 North America Sustained Release Injectables Market Under COVID-19

5.2 North America Sustained Release Injectables Consumption Volume by Types

5.3 North America Sustained Release Injectables Consumption Structure by Application

5.4 North America Sustained Release Injectables Consumption by Top Countries

5.4.1 United States Sustained Release Injectables Consumption Volume from 2016 to 2021

5.4.2 Canada Sustained Release Injectables Consumption Volume from 2016 to 2021

5.4.3 Mexico Sustained Release Injectables Consumption Volume from 2016 to 2021

Chapter 6 East Asia Sustained Release Injectables Market Analysis

6.1 East Asia Sustained Release Injectables Consumption and Value Analysis

6.1.1 East Asia Sustained Release Injectables Market Under COVID-19

6.2 East Asia Sustained Release Injectables Consumption Volume by Types

6.3 East Asia Sustained Release Injectables Consumption Structure by Application

6.4 East Asia Sustained Release Injectables Consumption by Top Countries

6.4.1 China Sustained Release Injectables Consumption Volume from 2016 to 2021

6.4.2 Japan Sustained Release Injectables Consumption Volume from 2016 to 2021

6.4.3 South Korea Sustained Release Injectables Consumption Volume from 2016 to 2021

Chapter 7 Europe Sustained Release Injectables Market Analysis

7.1 Europe Sustained Release Injectables Consumption and Value Analysis

7.1.1 Europe Sustained Release Injectables Market Under COVID-19

7.2 Europe Sustained Release Injectables Consumption Volume by Types

7.3 Europe Sustained Release Injectables Consumption Structure by Application

7.4 Europe Sustained Release Injectables Consumption by Top Countries

7.4.1 Germany Sustained Release Injectables Consumption Volume from 2016 to 2021

7.4.2 UK Sustained Release Injectables Consumption Volume from 2016 to 2021

7.4.3 France Sustained Release Injectables Consumption Volume from 2016 to 2021

7.4.4 Italy Sustained Release Injectables Consumption Volume from 2016 to 2021

7.4.5 Russia Sustained Release Injectables Consumption Volume from 2016 to 2021

7.4.6 Spain Sustained Release Injectables Consumption Volume from 2016 to 2021

7.4.7 Netherlands Sustained Release Injectables Consumption Volume from 2016 to 2021

7.4.8 Switzerland Sustained Release Injectables Consumption Volume from 2016 to 2021

7.4.9 Poland Sustained Release Injectables Consumption Volume from 2016 to 2021

Chapter 8 South Asia Sustained Release Injectables Market Analysis

8.1 South Asia Sustained Release Injectables Consumption and Value Analysis

8.1.1 South Asia Sustained Release Injectables Market Under COVID-19

8.2 South Asia Sustained Release Injectables Consumption Volume by Types

8.3 South Asia Sustained Release Injectables Consumption Structure by Application

8.4 South Asia Sustained Release Injectables Consumption by Top Countries

8.4.1 India Sustained Release Injectables Consumption Volume from 2016 to 2021

8.4.2 Pakistan Sustained Release Injectables Consumption Volume from 2016 to 2021

8.4.3 Bangladesh Sustained Release Injectables Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia Sustained Release Injectables Market Analysis

9.1 Southeast Asia Sustained Release Injectables Consumption and Value Analysis

9.1.1 Southeast Asia Sustained Release Injectables Market Under COVID-19

9.2 Southeast Asia Sustained Release Injectables Consumption Volume by Types

9.3 Southeast Asia Sustained Release Injectables Consumption Structure by Application

9.4 Southeast Asia Sustained Release Injectables Consumption by Top Countries

9.4.1 Indonesia Sustained Release Injectables Consumption Volume from 2016 to 2021

9.4.2 Thailand Sustained Release Injectables Consumption Volume from 2016 to 2021

9.4.3 Singapore Sustained Release Injectables Consumption Volume from 2016 to 2021

9.4.4 Malaysia Sustained Release Injectables Consumption Volume from 2016 to 2021

9.4.5 Philippines Sustained Release Injectables Consumption Volume from 2016 to 2021

9.4.6 Vietnam Sustained Release Injectables Consumption Volume from 2016 to 2021

9.4.7 Myanmar Sustained Release Injectables Consumption Volume from 2016 to 2021

Chapter 10 Middle East Sustained Release Injectables Market Analysis

10.1 Middle East Sustained Release Injectables Consumption and Value Analysis

10.1.1 Middle East Sustained Release Injectables Market Under COVID-19

10.2 Middle East Sustained Release Injectables Consumption Volume by Types

10.3 Middle East Sustained Release Injectables Consumption Structure by Application

10.4 Middle East Sustained Release Injectables Consumption by Top Countries

10.4.1 Turkey Sustained Release Injectables Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia Sustained Release Injectables Consumption Volume from 2016 to 2021

10.4.3 Iran Sustained Release Injectables Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates Sustained Release Injectables Consumption Volume from 2016 to 2021

10.4.5 Israel Sustained Release Injectables Consumption Volume from 2016 to 2021

10.4.6 Iraq Sustained Release Injectables Consumption Volume from 2016 to 2021

10.4.7 Qatar Sustained Release Injectables Consumption Volume from 2016 to 2021

10.4.8 Kuwait Sustained Release Injectables Consumption Volume from 2016 to 2021

10.4.9 Oman Sustained Release Injectables Consumption Volume from 2016 to 2021

Chapter 11 Africa Sustained Release Injectables Market Analysis

11.1 Africa Sustained Release Injectables Consumption and Value Analysis

11.1.1 Africa Sustained Release Injectables Market Under COVID-19

11.2 Africa Sustained Release Injectables Consumption Volume by Types

11.3 Africa Sustained Release Injectables Consumption Structure by Application

11.4 Africa Sustained Release Injectables Consumption by Top Countries

11.4.1 Nigeria Sustained Release Injectables Consumption Volume from 2016 to 2021

11.4.2 South Africa Sustained Release Injectables Consumption Volume from 2016 to 2021

11.4.3 Egypt Sustained Release Injectables Consumption Volume from 2016 to 2021

11.4.4 Algeria Sustained Release Injectables Consumption Volume from 2016 to 2021

11.4.5 Morocco Sustained Release Injectables Consumption Volume from 2016 to 2021

Chapter 12 Oceania Sustained Release Injectables Market Analysis

12.1 Oceania Sustained Release Injectables Consumption and Value Analysis

12.2 Oceania Sustained Release Injectables Consumption Volume by Types

12.3 Oceania Sustained Release Injectables Consumption Structure by Application

12.4 Oceania Sustained Release Injectables Consumption by Top Countries

12.4.1 Australia Sustained Release Injectables Consumption Volume from 2016 to 2021

12.4.2 New Zealand Sustained Release Injectables Consumption Volume from 2016 to 2021

Chapter 13 South America Sustained Release Injectables Market Analysis

13.1 South America Sustained Release Injectables Consumption and Value Analysis

13.1.1 South America Sustained Release Injectables Market Under COVID-19

13.2 South America Sustained Release Injectables Consumption Volume by Types

13.3 South America Sustained Release Injectables Consumption Structure by Application

13.4 South America Sustained Release Injectables Consumption Volume by Major Countries

13.4.1 Brazil Sustained Release Injectables Consumption Volume from 2016 to 2021

13.4.2 Argentina Sustained Release Injectables Consumption Volume from 2016 to 2021

13.4.3 Columbia Sustained Release Injectables Consumption Volume from 2016 to 2021

13.4.4 Chile Sustained Release Injectables Consumption Volume from 2016 to 2021

13.4.5 Venezuela Sustained Release Injectables Consumption Volume from 2016 to 2021

13.4.6 Peru Sustained Release Injectables Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico Sustained Release Injectables Consumption Volume from 2016 to 2021

13.4.8 Ecuador Sustained Release Injectables Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in Sustained Release Injectables Business

14.1 AstraZeneca

14.1.1 AstraZeneca Company Profile

14.1.2 AstraZeneca Sustained Release Injectables Product Specification

14.1.3 AstraZeneca Sustained Release Injectables Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 Biomarin

14.2.1 Biomarin Company Profile

14.2.2 Biomarin Sustained Release Injectables Product Specification

14.2.3 Biomarin Sustained Release Injectables Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 Roche

14.3.1 Roche Company Profile

14.3.2 Roche Sustained Release Injectables Product Specification

14.3.3 Roche Sustained Release Injectables Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 Eli Lilly

14.4.1 Eli Lilly Company Profile

14.4.2 Eli Lilly Sustained Release Injectables Product Specification

14.4.3 Eli Lilly Sustained Release Injectables Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 Avadel

14.5.1 Avadel Company Profile

14.5.2 Avadel Sustained Release Injectables Product Specification

14.5.3 Avadel Sustained Release Injectables Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 Sanofi

14.6.1 Sanofi Company Profile

14.6.2 Sanofi Sustained Release Injectables Product Specification

14.6.3 Sanofi Sustained Release Injectables Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.7 Critical Pharmaceuticals

14.7.1 Critical Pharmaceuticals Company Profile

14.7.2 Critical Pharmaceuticals Sustained Release Injectables Product Specification

14.7.3 Critical Pharmaceuticals Sustained Release Injectables Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.8 Aurobindo

14.8.1 Aurobindo Company Profile

14.8.2 Aurobindo Sustained Release Injectables Product Specification

14.8.3 Aurobindo Sustained Release Injectables Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.9 Novartis

14.9.1 Novartis Company Profile

14.9.2 Novartis Sustained Release Injectables Product Specification

14.9.3 Novartis Sustained Release Injectables Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.10 Camurus

14.10.1 Camurus Company Profile

14.10.2 Camurus Sustained Release Injectables Product Specification

14.10.3 Camurus Sustained Release Injectables Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.11 Alkermes

14.11.1 Alkermes Company Profile

14.11.2 Alkermes Sustained Release Injectables Product Specification

14.11.3 Alkermes Sustained Release Injectables Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.12 Taiwan Liposome Company

14.12.1 Taiwan Liposome Company Company Profile

14.12.2 Taiwan Liposome Company Sustained Release Injectables Product Specification

14.12.3 Taiwan Liposome Company Sustained Release Injectables Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.13 Amylin

14.13.1 Amylin Company Profile

14.13.2 Amylin Sustained Release Injectables Product Specification

14.13.3 Amylin Sustained Release Injectables Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.14 Ascendis Pharma

14.14.1 Ascendis Pharma Company Profile

14.14.2 Ascendis Pharma Sustained Release Injectables Product Specification

14.14.3 Ascendis Pharma Sustained Release Injectables Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global Sustained Release Injectables Market Forecast (2022-2027)

15.1 Global Sustained Release Injectables Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global Sustained Release Injectables Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global Sustained Release Injectables Value and Growth Rate Forecast (2022-2027)

15.2 Global Sustained Release Injectables Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global Sustained Release Injectables Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global Sustained Release Injectables Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America Sustained Release Injectables Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia Sustained Release Injectables Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe Sustained Release Injectables Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia Sustained Release Injectables Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia Sustained Release Injectables Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East Sustained Release Injectables Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa Sustained Release Injectables Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania Sustained Release Injectables Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America Sustained Release Injectables Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global Sustained Release Injectables Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global Sustained Release Injectables Consumption Forecast by Type (2022-2027)

15.3.2 Global Sustained Release Injectables Revenue Forecast by Type (2022-2027)

15.3.3 Global Sustained Release Injectables Price Forecast by Type (2022-2027)

15.4 Global Sustained Release Injectables Consumption Volume Forecast by Application (2022-2027)

15.5 Sustained Release Injectables Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology